Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Lloyd

Showing results (481-490 of 624) with videos related to

Pageof 63
Sort By:
The New England Journal of Medicine|July 22, 2005
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgeryGeoffrey J Service, Geoffrey B Thompson, F John Service, et al.
Annals of Surgery|February 1, 1984
Cystic neuroendocrine neoplasms of the pancreas and liverN W Thompson, F E Eckhauser, A I Vinik, et al.
The American Journal of Surgical Pathology|January 16, 2009
Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled ScoreDavid Wu, Arthur S Tischler, Ricardo V Lloyd, et al.
The American Journal of Surgical Pathology|January 26, 2013
Islet-1 is a sensitive but not entirely specific marker for pancreatic neuroendocrine neoplasms and their metastasesRondell P Graham, Bijayee Shrestha, Bolette L Caron, et al.
Surgery|November 13, 2018
Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancersDanilea M Carmona Matos, Samuel Jang, Baraa Hijaz, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1986
Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretionD E Schteingart, R V Lloyd, H Akil, et al.
The American Journal of Surgical Pathology|July 4, 2009
KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markersLizhi Zhang, Thomas C Smyrk, Andre M Oliveira, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 27, 2003
In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue sectionR T Hayden, P A Isotalo, T Parrett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 21, 2004
Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomasOnder Onguru, Bernd W Scheithauer, Kalman Kovacs, et al.
The American Journal of Pathology|December 10, 1998
Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomasH Oka, L Jin, J C Reubi, et al.
Pageof 63

Showing results (481-490 of 624) with videos related to

Sort By:
Pageof 63
The New England Journal of Medicine|July 22, 2005
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgeryGeoffrey J Service, Geoffrey B Thompson, F John Service, et al.
Annals of Surgery|February 1, 1984
Cystic neuroendocrine neoplasms of the pancreas and liverN W Thompson, F E Eckhauser, A I Vinik, et al.
The American Journal of Surgical Pathology|January 16, 2009
Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled ScoreDavid Wu, Arthur S Tischler, Ricardo V Lloyd, et al.
The American Journal of Surgical Pathology|January 26, 2013
Islet-1 is a sensitive but not entirely specific marker for pancreatic neuroendocrine neoplasms and their metastasesRondell P Graham, Bijayee Shrestha, Bolette L Caron, et al.
Surgery|November 13, 2018
Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancersDanilea M Carmona Matos, Samuel Jang, Baraa Hijaz, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1986
Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretionD E Schteingart, R V Lloyd, H Akil, et al.
The American Journal of Surgical Pathology|July 4, 2009
KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markersLizhi Zhang, Thomas C Smyrk, Andre M Oliveira, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 27, 2003
In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue sectionR T Hayden, P A Isotalo, T Parrett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 21, 2004
Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomasOnder Onguru, Bernd W Scheithauer, Kalman Kovacs, et al.
The American Journal of Pathology|December 10, 1998
Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomasH Oka, L Jin, J C Reubi, et al.
Pageof 63